This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Chd and n-3 polyunsaturated fatty acids

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

There is contrasting evidence for the benefits of omega -3 fatty acids (n-3 polyunsaturated fatty acids) in patients with ischaemic heart disease

Asystematic review of the literature on the effects of omega-3 fatty acids (n-3 FAs) (consumed as fish or fish oils rich in eicosapentaenoic acid and docosahexaenoic acid or as alpha-linolenic acid) on cardiovascular disease outcomes and adverse events was conducted (1)

  • the authors concluded that the evidence suggests that increased consumption of n-3 FAs from fish or fish-oil supplements, but not of alpha-linolenic acid, reduces the rates of all-cause mortality, cardiac and sudden death, and possibly stroke. The evidence for the benefits of fish oil is stronger in secondary- than in primary-prevention settings

n-3 PUFAs and arrhythmias

  • some authors state that the early effect of low-dose (1 g/d) omega-3 fatty acids on total mortality and sudden death supports the hypothesis of an antiarrhythmic effect of this drug. Such a result is consistent with the wealth of evidence coming from laboratory experiments on isolated myocytes, animal models, and epidemiological and clinical studies (2)
  • a systematic review and meta-analysis investigating the role of fish oil on arrhythmias and mortality however concluded that (3):
    • fish oil supplementation was associated with a significant reduction in deaths from cardiac causes but had no effect on arrhythmias or all cause mortality

n-3 PUFAs in chronic heart failure

  • there is evidence from the GISS-HF Investigators that n-3 PUFAs reduce morbidity and mortality in chronic heart failure (4)
  • note however that:
    • among patients with a recent episode of sustained ventricular arrhythmia and an implantable cardioverter defibrillator (ICD), fish oil supplementation did not reduce the risk of ventricular tachycardia (VT)/ ventricular fibrillation (VF) and may be proarrhythmic in some patients (5)

NICE state (6):

  • do not offer or advise people to use the following to prevent another MI:
    • omega-3 fatty acid capsules
    • omega-3 fatty acid supplemented foods

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.